Four-Gene Signature Predicts Aggressive Prostate Cancer
February 17th 2011In a study reported in Nature online on February 2, researchers describe a four-gene signature that was more accurate than the standard Gleason score test in predicting which patients would die from metastatic spread of their prostate cancer.
Falls Are Key in Patient Assessment and Planning
February 16th 2011Falls and the risk of falls are critical health concerns that can impact cancer treatment and recovery. In 2007, the Centers for Disease Control (CDC) reported that more than 18,000 older adults in the United States died from injuries sustained from falls (CDC, 2010).[1] Older people diagnosed with a malignancy and who are undergoing cancer treatment using chemotherapy have an increased risk of falls.[2]
Fall Risk Assessment and Prevention
February 16th 2011Patient falls are a common cause of morbidity and are the leading cause of injury deaths in adults age 65 years and older. Injuries sustained as result of falls in a cancer hospital are often severe, regardless of patient age, due to the nature of the underlying cancer.
Care of the Older Adult With Cancer
February 16th 2011One area in which to start is to ensure that colleagues are aware of the 2007 Oncology Nursing Society (ONS) Position Paper on cancer in the elderly.[8] This position paper lays out the landscape of caring for older adults with cancer both in terms of problems to date and future initiatives to address.
Cabazitaxel, a Taxane for Men With Hormone-Refractory Metastatic Prostate Cancer
October 19th 2010Cabazitaxel is a microtubule inhibitor in the taxane class. It is made from a yew needle precursor using a semisynthetic process. It binds to free tubulin, which is used during mitosis to form two daughter cells.